• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梅西纳省病原体及呼吸道合并感染的趋势:从儿童期到老年期

Trend of pathogens and respiratory co-infections in the province of Messina: from pediatric age to senescence.

作者信息

Genovese Cristina, Gorgone Miriam, Genovese Giovanni, LA Spada Giuseppe, Balsamo Danila, Calderone Serena Maria, Faranda Irene, Squeri Raffaele

机构信息

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy.

Post Graduate School of Hygiene and Preventive Medicine, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy.

出版信息

J Prev Med Hyg. 2024 Oct 31;65(3):E344-E355. doi: 10.15167/2421-4248/jpmh2024.65.3.3344. eCollection 2024 Sep.

DOI:10.15167/2421-4248/jpmh2024.65.3.3344
PMID:39758766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698104/
Abstract

Acute respiratory infections (ARI) are a leading cause of global morbidity and mortality and they're primarily caused by viruses such as rhinovirus, coronavirus, and respiratory syncytial virus (RSV), and to a lesser extent by bacteria like Streptococcus pneumoniae and Mycoplasma pneumoniae. The study examines the impact of COVID-19 control measures on the circulation of respiratory pathogens, indicating a reduction in infections during the pandemic period. A retrospective study was conducted on 1,286 patients at the "G. Martino" University Hospital of Messina to evaluate the prevalence of respiratory pathogens. The results showed that SARS-CoV-2, rhinovirus, and RSV are the most frequently isolated pathogens, with a clear seasonality from December to March. Co-infections were detected in 14.1% of cases, predominantly in young children. The study suggests the need for enhanced surveillance strategies to improve the management of respiratory infections and healthcare resources.

摘要

急性呼吸道感染(ARI)是全球发病和死亡的主要原因,主要由鼻病毒、冠状病毒和呼吸道合胞病毒(RSV)等病毒引起,在较小程度上也由肺炎链球菌和肺炎支原体等细菌引起。该研究考察了新冠疫情防控措施对呼吸道病原体传播的影响,表明在疫情期间感染有所减少。在墨西拿“G. 马尔蒂诺”大学医院对1286名患者进行了一项回顾性研究,以评估呼吸道病原体的流行情况。结果显示,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、鼻病毒和呼吸道合胞病毒是最常分离出的病原体,在12月至3月有明显的季节性。14.1%的病例检测到合并感染,主要发生在幼儿中。该研究表明需要加强监测策略,以改善呼吸道感染的管理和医疗资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/72e3078ecc42/jpmh-2024-03-e344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/d4cba53aaaf9/jpmh-2024-03-e344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/9b705ca2999f/jpmh-2024-03-e344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/72e3078ecc42/jpmh-2024-03-e344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/d4cba53aaaf9/jpmh-2024-03-e344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/9b705ca2999f/jpmh-2024-03-e344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/becd/11698104/72e3078ecc42/jpmh-2024-03-e344-g003.jpg

相似文献

1
Trend of pathogens and respiratory co-infections in the province of Messina: from pediatric age to senescence.梅西纳省病原体及呼吸道合并感染的趋势:从儿童期到老年期
J Prev Med Hyg. 2024 Oct 31;65(3):E344-E355. doi: 10.15167/2421-4248/jpmh2024.65.3.3344. eCollection 2024 Sep.
2
Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.美国一家大型学术医疗中心的呼吸道病毒疾病和结局:2023/2024 年呼吸道病毒季节早期的回顾性观察研究。
Microbiol Spectr. 2024 Oct 3;12(10):e0111624. doi: 10.1128/spectrum.01116-24. Epub 2024 Aug 20.
3
Temporal trends in respiratory pathogens following the COVID-19 pandemic and climate variables: A unicentric retrospective evaluation of 24 pathogens in a temperate subtropical region.新冠疫情后呼吸病原体与气候变量的时间趋势:温带亚热带地区 24 种病原体的单中心回顾性评估。
J Med Virol. 2024 Jul;96(7):e29797. doi: 10.1002/jmv.29797.
4
Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness-Valencia Region, Spain, 2010-2021.2010-2021 年西班牙巴伦西亚地区急性呼吸道疾病住院患者中呼吸道病毒感染的季节性和共检出情况。
Influenza Other Respir Viruses. 2024 Oct;18(10):e70017. doi: 10.1111/irv.70017.
5
Respiratory pathogen spectrum and epidemiological trends in Hainan Province: a retrospective analysis from 2017 to 2023.海南省呼吸道病原体谱及流行病学趋势:2017年至2023年回顾性分析
BMC Infect Dis. 2025 Feb 7;25(1):192. doi: 10.1186/s12879-025-10493-6.
6
Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID-19 pandemic and after easing of COVID-19 restrictions.COVID-19 大流行期间和放宽 COVID-19 限制后急性呼吸道感染患者中呼吸道病原体的流行病学。
Microbiol Spectr. 2024 Nov 5;12(11):e0116124. doi: 10.1128/spectrum.01161-24. Epub 2024 Sep 25.
7
The Epidemiology of Respiratory Syncytial Virus and the Impact of the COVID-19 Pandemic in a Retrospective Evaluation.呼吸道合胞病毒的流行病学及COVID-19大流行在一项回顾性评估中的影响
Pathogens. 2025 Apr 11;14(4):375. doi: 10.3390/pathogens14040375.
8
Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023.揭示2020 - 2023年台湾地区新冠疫情期间多重PCR检测所揭示的呼吸道感染动态。
J Microbiol Immunol Infect. 2024 Dec;57(6):868-878. doi: 10.1016/j.jmii.2024.08.003. Epub 2024 Aug 12.
9
One-year epidemiological patterns of respiratory pathogens across age, gender, and seasons in Chengdu during the post-COVID era.新冠疫情后时代成都呼吸道病原体在年龄、性别和季节方面的一年流行病学模式。
Sci Rep. 2025 Jan 2;15(1):357. doi: 10.1038/s41598-024-84586-8.
10
Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic.评估 COVID-19 大流行爆发后季节性呼吸道病毒流行病学的变化。
J Gen Virol. 2024 May;105(5). doi: 10.1099/jgv.0.001981.

本文引用的文献

1
Chlamydia pneumoniae Upsurge at Tertiary Hospital, Lausanne, Switzerland.瑞士洛桑一家教学医院中新现肺炎衣原体感染。
Emerg Infect Dis. 2024 Apr;30(4):810-812. doi: 10.3201/eid3004.231610. Epub 2024 Feb 27.
2
Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg.2023/24赛季初期,尼塞韦单抗预防对卢森堡儿童呼吸道合胞病毒(RSV)相关住院治疗的影响。
Euro Surveill. 2024 Jan;29(4). doi: 10.2807/1560-7917.ES.2024.29.4.2400033.
3
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
肺炎支原体:在新冠疫情限制措施后延迟再现。
Lancet Microbe. 2024 Feb;5(2):e100-e101. doi: 10.1016/S2666-5247(23)00344-0. Epub 2023 Nov 23.
4
Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.SARS-CoV-2 大流行期间儿童呼吸道病毒的流行病学:系统评价和荟萃分析。
Int J Infect Dis. 2024 Jan;138:10-18. doi: 10.1016/j.ijid.2023.10.023. Epub 2023 Nov 10.
5
Reshaping Our Knowledge: Advancements in Understanding the Immune Response to Human Respiratory Syncytial Virus.重塑我们的认知:在理解人类呼吸道合胞病毒免疫反应方面取得的进展
Pathogens. 2023 Sep 1;12(9):1118. doi: 10.3390/pathogens12091118.
6
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《使用尼赛珠单抗预防婴幼儿呼吸道合胞病毒疾病:免疫实践咨询委员会的建议-美国,2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):920-925. doi: 10.15585/mmwr.mm7234a4.
7
Why has the epidemiology of RSV changed during the COVID-19 pandemic?在新冠疫情期间,呼吸道合胞病毒的流行病学为何发生了变化?
EClinicalMedicine. 2023 Jul 6;61:102089. doi: 10.1016/j.eclinm.2023.102089. eCollection 2023 Jul.
8
Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.评估 2022 年流感和 RSV 再次流行期间儿科人群中合并感染发生率的呼吸道病毒排除和亲和相互作用。
Front Cell Infect Microbiol. 2023 Jun 14;13:1208235. doi: 10.3389/fcimb.2023.1208235. eCollection 2023.
9
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data.老年人呼吸道合胞病毒感染的发病率:当前数据的局限性
Infect Dis Ther. 2023 Jun;12(6):1487-1504. doi: 10.1007/s40121-023-00802-4. Epub 2023 May 23.
10
Vaccine hesitancy in pregnant Women: A narrative review.孕妇对疫苗的犹豫:一个叙述性综述。
Vaccine. 2023 Jun 29;41(29):4220-4227. doi: 10.1016/j.vaccine.2023.05.047. Epub 2023 Jun 7.